Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06349798
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-01-23
Brief Title:
Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty NEFARTHRO
Sponsor:
University Hospital Tours
Organization:
University Hospital Tours
Study Overview
Official Title:
Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty NEFARTHRO a Multicentric Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NEFARTHRO
Brief Summary:
NEFARTHRO is a multicentric randomized controlled trial comparing the effects of discontinuous infusions of nefopam bolus versus continuous infusion of intravenous nefopam via an infusion pump versus placebo on the opioid-request during the first 24 hours following a Total Hip arthroplasty as part of multimodal analgesia including at least paracetamol and a Non-Steroidal Anti-Inflammatory Drug NSAID
The primary endpoint is cumulative morphine consumption for the first postoperative 24 hours expressed in mg of iv equivalent morphine including titration in the Post Anesthesia Care Unit PACU
Patients will be followed during 6 months
The primary endpoint is cumulative morphine consumption for the first postoperative 24 hours expressed in mg of iv equivalent morphine including titration in the Post Anesthesia Care Unit PACU
Patients will be followed during 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None